NADER BOUTROS: Open Payments
NPI 1376002683 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 11 payments from 5 companies in 2025. Trend: 2023 $212 · 2024 $405 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $111 |
| ABBVIE INC. | 4 | $98 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Lilly USA, LLC | 1 | $33 |
| Eisai Inc. | 1 | $29 |
Products named: Rystiggo, QULIPTA, WAINUA, UBRELVY, KISUNLA, Leqembi, BOTOX.
Industry payments across CA — which companies pay providers there.
